Emergent Biosolutions El-Hibri

Fuad El-Hibri has filed an intention with the SEC to sell 1.1 million shares of stock:

On January 20, 2009, Emergent Biosolutions announces that Fuad El-Hibri has filed an intention with the SEC to sell 1.1 million shares of stock: 13.5 million shares had been issued to date with 47% controlled by Fuad El-Hibri. It also announced Stage II testing of vaccines for Typhoid, Hepatitis B, and Tuberculosis.

Related posts:

  1. Fuad El-Hibri on AOL Money For commercial markets, Emergent is working on therapies and...
  2. Board expands with Election of Fuad El-Hibri NHM Chairman Louis Sullivan, MD, has announced the election of...
  3. Fuad El-Hibri Yale Health Care Advisory Board Mr. Fuad El-Hibri has served as chief executive officer and...

Related posts brought to you by Yet Another Related Posts Plugin.

Submitted by admin on Fri, 08/14/2009 - 05:04.